Reduced pancreatitis risk tied to liraglutide use in diabetes, study finds

http://type2diabetestreatment.net/diabetes-research/reduced-pancreatitis-risk-tied-to-liraglutide-use-in-diabetes-study-finds/

A study in Diabetes Care showed that 51.3% of adults with type 2 diabetes and high cardiovascular risk experienced at least one increased lipase level over time and 29% had at least one elevated amylase level over time after receiving liraglutide for an average of 3.84 years, compared with 31.8% and 22.9% of those in the placebo group. Researchers used a cohort of 9,340 patients and found that 18 of those in the liraglutide group had a confirmed acute pancreatitis event, compared with 23 in the placebo group.

Type 2 Diabetes Treatment
Type 2 Diabetes Diet
Diabetes Destroyer Reviews
Original Article
#Diabetes_Research
#obesity_help